In addition, anti-angiogenesis therapy has been regarded as a new era for tumor treatment in recent years, and targeting the tumor neovascularization, including CD13 and integrin αvβ3, has become a widely accepted therapeutic strategy in clinic (46, 47). Here, ANPEP is linked to neoplasm.